Shanghai, China

Qianqian Shen

USPTO Granted Patents = 2 

 

 

Average Co-Inventor Count = 9.9

ph-index = 1


Company Filing History:


Years Active: 2021-2023

where 'Filed Patents' based on already Granted Patents

2 patents (USPTO):

Title: Qianqian Shen: Innovator in Pharmaceutical Compounds

Introduction

Qianqian Shen is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with potential therapeutic applications. With a total of 2 patents, his work focuses on innovative solutions for treating tumors and autoimmune diseases.

Latest Patents

One of Qianqian Shen's latest patents is for indolizine compounds, which includes a preparation method and their use. This invention provides an indolizine compound represented by a specific formula or a pharmaceutically acceptable salt thereof. The compound exhibits an inhibitory effect on wild-type and/or mutant EZH2 or EZH1, indicating its potential as a novel drug for anti-tumor therapies or the treatment of autoimmune diseases.

Another significant patent involves a pyrido five-element aromatic ring compound, along with its preparation method and use. This compound also demonstrates an inhibitory effect on wild-type and/or mutant EZH2, positioning it as a promising candidate for development into a novel anti-tumor drug or a treatment for autoimmune diseases.

Career Highlights

Qianqian Shen has worked with Haihe Biopharma Co., Ltd. and Shanghai Haihe Pharmaceutical Co., Ltd., where he has contributed to various research and development projects. His expertise in pharmaceutical compounds has been instrumental in advancing the capabilities of these companies in the industry.

Collaborations

Qianqian has collaborated with notable colleagues, including Xuxing Chen and Yi Chen, who have contributed to his research endeavors. Their combined efforts have enhanced the development of innovative pharmaceutical solutions.

Conclusion

Qianqian Shen's work in the field of pharmaceutical compounds showcases his dedication to innovation and the potential for significant advancements in medical treatments. His patents reflect a commitment to addressing critical health challenges through scientific research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…